P. D. Williams

发表

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues.

D. Veber, M. Bock, R. Freidinger, 1992, Life sciences.

L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm labor

B. E. Evans, M. Kaufman, D. Veber, 1993 .

1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.

B. E. Evans, M. Bock, P. Anderson, 1994, Journal of medicinal chemistry.

Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors.

C. Coburn, J. Vacca, S. D. Lewis, 2000, Bioorganic & medicinal chemistry letters.

Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency.

B. E. Evans, M A Jacobson, M. Bock, 1999, Bioorganic & medicinal chemistry letters.

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.

D. Veber, R. Freidinger, D. Reiss, 1995, Journal of medicinal chemistry.

Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product.

M. Bock, W. L. Whitter, G. F. Lundell, 1992, Journal of medicinal chemistry.

Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors.

C. Coburn, J. Vacca, S. D. Lewis, 2000, Bioorganic & medicinal chemistry letters.

Synthesis and structure of R2R*2Mo4S4 cubane clusters (R, R*=Cp, Cp', Cp*): an affirmation of the Dahl binding model

M. Curtis, P. D. Williams, 1986 .

Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications.

M. Bock, R. M. Dipardo, R. Freidinger, 1990, Journal of medicinal chemistry.

Internal electron transfer in some four- and five-coordinate macrocyclic complexes with copper and nickel

J. Burdett, P. D. Williams, 1980 .

Metal-metal multiple bonds. Part 11. Metal-metal multiple bonds in rational cluster synthesis. Novel isomerism in iron-molybdenum-sulfur clusters and a molybdenum-sulfur cubane. Structure of (.eta.5-CH3C5H4)2Mo2Fe2(.mu.3-S)2(CO)6(.mu.-CO)2

M. Curtis, W. Butler, P. D. Williams, 1983 .

Preparation, structures, and electrochemistry of tetranuclear sulfido clusters Cp2M2M'2S2-4 (M = molybdenum, tungsten; M' = iron, cobalt, nickel)

M. Curtis, W. Butler, P. D. Williams, 1988 .

Structural characterization of the sulfur-capped triangulo cluster, Cp2W2Fe(CO)7(S)

M. Curtis, P. D. Williams, 1988 .

Preparation, Structures, and Electrochemistry of Tetranuclear Sulfido Clusters Cp2M2M′2S2-4 (M: Mo, W; M′: Fe, Co, Ni).

M. Curtis, W. Butler, P. D. Williams, 1988 .

Facile synthesis of Cp2Mo2(.mu.-SH)2(.mu.-S)2 and its use in heterobimetallic cluster synthesis

M. Curtis, P. D. Williams, 1983 .

METHANATION AND HDS CATALYSTS BASED ON SULFIDED, BIMETALLIC CLUSTERS.

L. Thompson, J. Schwank, M. Curtis, 1986 .

Aqueous Dispersion and Slip Casting of Boron Carbide Powder: Effect of pH and Oxygen Content

D. Hawn, P. D. Williams, P. Williams, 1991 .

New Low Temperature Processing for Boron Carbide/Aluminum Based Composite Armor

A. Pyzik, P. D. Williams, A. McCombs, 1990 .

Nanomolar-affinity, non-peptide oxytocin receptor antagonists.

B. E. Evans, K. Rittle, M. Bock, 1993, Journal of medicinal chemistry.

Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology.

J. Renger, P. Coleman, A. Gotter, 2016, Bioorganic & medicinal chemistry letters.

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.

S Vickers, R. Freidinger, D. Reiss, 1998, Journal of medicinal chemistry.

Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation.

D. Veber, R. Freidinger, R. Ball, 1994, Bioorganic & medicinal chemistry.

Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.

R J Lynch, M. Holloway, J. Doyle, 1991, Journal of medicinal chemistry.

Bradykinin agonist activity of a novel, potent oxytocin antagonist.

D. Veber, M. Bock, R. Freidinger, 1991, European Journal of Pharmacology.

Potent and selective cyclic hexapeptide oxytocin antagonists

D. Veber, M. Bock, R. M. Dipardo, 1991 .

Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide.

D. Veber, M. Bock, R. M. Dipardo, 1990, Journal of medicinal chemistry.